DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,238,392 | -23.6% | 2,531,835 | +9.2% | 0.01% | -25.0% |
| Q2 2023 | $68,412,963 | +38.4% | 2,318,297 | +8.0% | 0.01% | +33.3% |
| Q1 2023 | $49,447,819 | +86636.9% | 2,146,172 | +4.7% | 0.01% | -25.0% |
| Q4 2022 | $57,009 | -99.9% | 2,049,957 | +15.4% | 0.01% | 0.0% |
| Q3 2022 | $54,510,000 | +8.5% | 1,776,164 | +4.1% | 0.01% | +14.3% |
| Q2 2022 | $50,224,000 | -4.3% | 1,706,581 | +4.6% | 0.01% | 0.0% |
| Q1 2022 | $52,467,000 | -27.8% | 1,630,947 | +0.1% | 0.01% | -22.2% |
| Q4 2021 | $72,647,000 | -10.4% | 1,628,867 | +1.3% | 0.01% | -18.2% |
| Q3 2021 | $81,093,000 | -31.9% | 1,607,394 | +6.0% | 0.01% | -31.2% |
| Q2 2021 | $118,995,000 | +66.3% | 1,517,021 | +21.1% | 0.02% | +45.5% |
| Q1 2021 | $71,536,000 | -26.0% | 1,252,832 | +8.5% | 0.01% | -31.2% |
| Q4 2020 | $96,734,000 | +148.6% | 1,154,902 | +6.3% | 0.02% | +100.0% |
| Q3 2020 | $38,916,000 | +48.9% | 1,086,129 | +0.5% | 0.01% | +33.3% |
| Q2 2020 | $26,137,000 | +51.9% | 1,080,950 | +10.0% | 0.01% | +50.0% |
| Q1 2020 | $17,203,000 | -43.1% | 982,519 | -43.4% | 0.00% | +33.3% |
| Q4 2019 | $30,226,000 | +134.1% | 1,735,236 | +105.9% | 0.00% | 0.0% |
| Q3 2019 | $12,911,000 | -24.5% | 842,771 | +2.3% | 0.00% | -25.0% |
| Q2 2019 | $17,098,000 | -4.8% | 823,633 | +6.4% | 0.00% | -20.0% |
| Q1 2019 | $17,968,000 | -38.8% | 773,887 | -45.5% | 0.01% | 0.0% |
| Q4 2018 | $29,338,000 | +90.2% | 1,420,044 | +100.2% | 0.01% | +25.0% |
| Q3 2018 | $15,421,000 | +390.6% | 709,345 | +244.1% | 0.00% | +300.0% |
| Q2 2018 | $3,143,000 | +7.8% | 206,150 | +39.2% | 0.00% | 0.0% |
| Q1 2018 | $2,915,000 | – | 148,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |